Suppr超能文献

等待和扫描策略或立体定向放射外科治疗小到中型前庭神经鞘瘤后的听力保护和生活质量:系统评价和荟萃分析。

Hearing preservation and quality of life in small to medium sized vestibular schwannomas after a wait and scan approach or stereotactic radiosurgery: a systematic review and meta-analysis.

机构信息

Dominican Gamma Knife Center, CEDIMAT, Caribbean, Santo Domingo, Dominican Republic.

Federal University of Piaui, Teresina, Piaui, Brazil.

出版信息

Acta Neurochir (Wien). 2024 Sep 9;166(1):361. doi: 10.1007/s00701-024-06249-x.

Abstract

BACKGROUND

The management of vestibular schwannomas (VS) encompasses a choice between conservative "wait-and-scan" (WAS) approach, stereotactic radiosurgery (SRS) or open microsurgical resection. Currently, there is no consensus on the optimal management approach for small to medium sized VS. This study aims to compared outcomes related to hearing in patients with small and medium sized VS who underwent initial treatment with WAS versus SRS.

METHODS

A systematic review of the available literature was conducted using PubMed/MEDLINE, Embase, and Cochrane up December 08, 2023. Meta-analysis was performed using a random-effect model to calculate mean difference (MD) and relative risk (RR). A leave-one-out analysis was conducted. The risk of bias was assessed via the Risk of Bias in Non-randomized Studies-Interventions (ROBINS-I) and Cochrane Risk of Bias assessment tool (RoB-2). Ultimately, the certainty of evidence was evaluated using the GRADE assessment. The primary outcomes were serviceable hearing, and pure-tone average (PTA). The secondary outcome was the Penn Acoustic Neuroma Quality of Life Scale (PANQOL) total score.

RESULTS

Nine studies were eligible for inclusion, comprising a total of 1,275 patients. Among these, 674 (52.86%) underwent WAS, while 601 patients (47.14%) received SRS. Follow-up duration ranged from two to eight years. The meta-analysis indicated that WAS had a better outcome for serviceable hearing (0.47; 95% CI: 0.32 - 0.68; p < 0.001), as well as for postoperative functional measures including PTA score (MD 13.48; 95% CI 3.83 - 23.13; p < 0.01), and PANQOL total score (MD 3.83; 95% CI 0.42 - 7.25; p = 0.03). The overall certainty of evidence ranged from "very low" to "moderate".

CONCLUSIONS

Treating small to medium sized VS with WAS increases the likelihood of preserving serviceable hearing and optimized PANQOL overall postoperative score compared to SRS. Nevertheless, the limited availability of literature and the methodological weakness observed in existing studies outline the need for higher-quality studies.

摘要

背景

听神经鞘瘤(VS)的治疗包括保守的“观察等待”(WAS)方法、立体定向放射外科(SRS)或开放式显微手术切除之间的选择。目前,对于小到中等大小的 VS,尚无关于最佳治疗方法的共识。本研究旨在比较接受 WAS 或 SRS 初始治疗的小到中等大小 VS 患者与听力相关的结果。

方法

使用 PubMed/MEDLINE、Embase 和 Cochrane 数据库系统地检索了截至 2023 年 12 月 8 日的可用文献。使用随机效应模型计算平均值差异(MD)和相对风险(RR)进行荟萃分析。进行了一项逐个剔除分析。通过风险偏倚评估工具(ROBINS-I)和 Cochrane 风险偏倚评估工具(RoB-2)评估风险偏倚。最终,使用 GRADE 评估评估证据的确定性。主要结局是可利用听力和纯音平均听阈(PTA)。次要结局是宾夕法尼亚听神经瘤生活质量量表(PANQOL)总分。

结果

有 9 项研究符合纳入标准,共纳入 1275 名患者。其中,674 名(52.86%)患者接受了 WAS,而 601 名患者(47.14%)接受了 SRS。随访时间从 2 年到 8 年不等。荟萃分析表明,WAS 对可利用听力(0.47;95%CI:0.32-0.68;p<0.001)和术后功能测量结果(包括 PTA 评分[MD 13.48;95%CI 3.83-23.13;p<0.01]和 PANQOL 总分[MD 3.83;95%CI 0.42-7.25;p=0.03])有更好的结局。总体证据确定性范围从“极低”到“中等”。

结论

与 SRS 相比,用 WAS 治疗小到中等大小的 VS 可增加保留可利用听力和优化术后总体 PANQOL 评分的可能性。然而,文献的有限可用性和现有研究中观察到的方法学弱点表明需要进行更高质量的研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验